Condition category
Musculoskeletal Diseases
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status

Plain English Summary

Background and study aims:
25,000 people in the UK have vertebral (spine) fractures related to their osteoporosis each year and many of these are referred for physiotherapy to help them recover after their fracture(s). Physiotherapy includes a variety of treatment options, such as exercise programmes or ‘hands on’ treatment like massage. At the moment there is some research evidence which suggests that physiotherapy may help to ease pain and help patients get back to their normal activities of daily life as soon as possible. However, we do not know which type of physiotherapy is most helpful to people, how much this treatment is costing the NHS, or what patients’ think of their treatment.
The research question: Which type of physiotherapy helps patients with osteoporosis recover most after vertebral fracture? The study will test exercise and manual treatments and compare patients who have had these treatments to patients who have usual care with no physiotherapy treatment. The research will also provide information about treatment costs, safety and about what patients think about their treatment.

Who can participate?
Men and women with a diagnosis of primary osteoporosis confirmed by radiograph and with at least 1 painful vertebral fracture. Female participants will need to have passed menopause. All participants will have had appropriate fracture prevention therapy, be able to walk independently with or without an aid for at least 10 metres and be able to participate in a physiotherapy programme.

What does the study involve?
Participants will be asked to attend three assessments, the first before any treatment happens, the second 14 weeks later and the third twelve months after the study starts. After the first assessment a computer programme will decide which study group the person will join: treatment as usual, manual physiotherapy or exercise physiotherapy groups. Every participant will continue taking any osteoporosis medication, and will be offered education about osteoporosis and support through the trial with telephone calls every 2 months. In addition, the treatment groups will be offered 6 sessions of physiotherapy and asked to carry out some activities and exercises at home.

What are the possible benefits and risks of participating?
All participants will have access to usual care, and no treatment will be withheld from any participant. There is a slight risk that the treatments could increase pain or may lead to an increase in further fracture rates (25% fracture rates may be seen in the control group) and we will monitor these carefully. If the trial is successful, future patients will benefit from the clarification of the best treatment package for treating this condition. Alternatively, we may demonstrate that physiotherapy interventions are not effective for this condition, thus allowing National Health Service resources to be saved and redirected to other more effective treatments

Where is the study run from?
University of Oxford

When is study starting and how long is it expected to run for?
It is anticipated that recruitment will start early in 2013. Participants will be enrolled into the study for a period of 18 months; with follow up of patients for one year. In total the study will run for 4 years.

Who is funding the study?
NIHR Health Technology Assessment Programme

Who is the main contact?
Dr Karen Barker

Trial website

Contact information



Primary contact

Dr Karen Barker


Contact details

Oxford University Hospitals NHS Trust
Physiotherapy Department
Nuffield Orthopaedic Centre
United Kingdom
+44 (0)1865 738080

Additional identifiers

EudraCT number

Nil known number

Nil known

Protocol/serial number


Study information

Scientific title

Physiotherapy Rehabilitation for Osteoporotic Vertebral fracture (PROVe)



Study hypothesis

Either manual therapy or exercise therapy will offer improved functional outcome than treatment as usual.

Sub study: Reliability of physical outcome measures for posture and back muscle strength. 60 patients completing 3 different measures to assess suitability, utility and reliability.

Ethics approval

South Central, 08/08/2012, ref: 12/SC/0411

Sub study: South Central, 07/08/2012, ref: SC 12/ 0390

Study design

Adaptive design multi-centred, three-arm randomised controlled trial with blinded assessments.

Sub study: Non-randomised observational cross-sectional study of three measures of spinal posture

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet




Physiotherapy either manual therapy or exercise based therapy - up to 7 sessions

Intervention type



Not Specified

Drug names

Primary outcome measure

QUALEFFO 41 Quality of Life questionnaire

Sub study- Inclinometer, tragus to wall, flexicurve measures for relaibility

Secondary outcome measures

1. Timed load stand test
2. Spinal posture
3. Short performance physical battery
4. Functional reach test, 6 minute walk, PASE questionnaire, EQ5D, pain VAS

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Men and women
2. A diagnosis of primary osteoporosis confirmed by radiograph or by DEXA scan of <= -2.5 at lowest lumbar level
3. At least 1 painful vertebral fracture sustained previously.
4. At different times post vertebral fracture and with different numbers and sites of fractures
5. Female participants will need to be postmenopausal as defined by the date of their last period which should be more than 2 years previously.
6. All participants will have had appropriate fracture prevention therapy under NICE TA 161, be able to walk independently with or without an aid at least 10 metres and be able to participate in a physiotherapy programme.

Participant type


Age group




Target number of participants


Total final enrolment


Participant exclusion criteria

1. Have any condition which might make participating in physiotherapy unsafe, including severe unstable cardiovascular or pulmonary disease, osteoporosis secondary to metabolic bone disorders or other disease and neurological disorders.
2. Those whose primary problem is back pain with radiating pain into the lower limb will be excluded as will individuals who have had vertebroplasty, facet joint injection or physical therapy e.g. chiropractic, osteopathy or physiotherapy treatment for back pain in the previous 12 weeks

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

Oxford University Hospitals NHS Trust
United Kingdom

Sponsor information


Oxford University Hospitals NHS Trust (UK)

Sponsor details

c/o Ms Heather House
Medical Research Services
Churchill Hospital
Old Road
United Kingdom

Sponsor type

Hospital/treatment centre



Funder type


Funder name

NIHR Health Technology Assessment Programme - HTA (UK) ref: 10/99/01

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Planned publication in a high impact peer-reviewed journal.

IPD sharing statement:
The datasets generated and/or analysed during the current study during this study will be included in the subsequent results publication.

Intention to publish date


Participant level data


Basic results (scientific)

Publication list

2019 results in: (added 29/08/2019)
2014 protocol in:

Publication citations

  1. Protocol

    Barker KL, Javaid MK, Newman M, Minns Lowe C, Stallard N, Campbell H, Gandhi V, Lamb S, Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture (PROVE): study protocol for a randomised controlled trial., Trials, 2014, 15, 22, doi: 10.1186/1745-6215-15-22.

Additional files

Editorial Notes

29/08/2019: Publication reference added. 30/05/2019: The total final enrolment was added. 19/01/2018: The overall trial end date has been updated from 30/12/2017 to 31/03/2018. The recruitment end date has been updated from 30/12/2017 to 05/09/2016. The intention to publish date has been added. The publication and dissemination plans have been added. The intention to publish date has been added. The participant level data sharing statement has been added.